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vate many downstream muscle genes (reviewed byFred Hutchinson Cancer Research Center
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revealed that these factors function hierarchically in my-University of Washington
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termining myoblast cell fate, whereas myogenin andSeattle, Washington 98195
possibly MRF4 are involved in terminal differentiation
of skeletal muscle (reviewed by Weintraub, 1993; Buck-
ingham, 1994; Olson and Klein, 1994; Olson et al., 1996).
Summary
In vertebrate embryos, the major axial structures, in-
cluding the vertebrae and skeletal muscle, are derived
During embryogenesis, cells from the ventral and dor- from somites. During somite maturation, the presomitic
sal parts of the somites give rise to sclerotome and mesoderm segments in a cranio-caudal direction to
dermomyotome, respectively. Dermomyotome con- form the epithelial somites. Subsequently, cells from the
tains skeletal muscle precursors that are determined ventral part of the epithelial somite delaminate to form
by the MyoD family of myogenic factors. We have iso- the sclerotome, which then gives rise to the vertebral
lated a novel myogenic repressor, I-mf (Inhibitor of column and ribs. Cells from the dorsal region of the
MyoD family), which is highly expressed in the sclero- epithelial somite comprise the dermomyotome and later
tome. In contrast, MyoD family members are concen- differentiate a dorsal layer of dermatome, which will give
trated in the dermomyotome. We demonstrate that rise to dermis, and a ventral layer of myotome, which
I-mf inhibits the transactivation activity of the MyoD will give rise to axial skeletal muscle (reviewed by
family and represses myogenesis. I-mf associates Keynes and Stern, 1988; Tam and Trainor, 1994).
with MyoD family members and retains them in the Development of the myotome and the sclerotome is
cytoplasm by masking their nuclear localization sig- dependent on signals from surrounding tissues. Signals
nals. I-mfcan also interfere with the DNAbinding activ- from the surface ectoderm and neural tube are required
ity of MyoD family members. We postulate that I-mf for inducing or maintaining the epithelial morphology of
plays an important role in the patterning of the somite the dermomyotome, as well as the expression of dermo-
early in development. myotomal genes and myogenic factors (Buffinger and
Stockdale, 1994; Fan and Tessier-Lavigne, 1994; MuÈn-
sterberg and Lassar, 1995); signals from the axial midlineIntroduction
tissue, the notochord and floor plate, are required for
sclerotome formation (Rong et al., 1992; Brand-Saberi etThe cell fate of skeletal muscle precursors is determined
al., 1993; Pourquie et al., 1993; Fan and Tessier-Lavigne,cell-autonomously by the expression of ªmaster genesº
1994; Goulding et al., 1994). Lineage tracing studiesencoding the MyoD family of myogenic regulatory fac-
have suggested the inheritance of cell fate plasticity intors. The members of thisfamily, myoD, myf5, myogenin,
presomitic mesoderm and epithelial somites (Stern etand MRF4, encode muscle-specific transcriptional reg-
al., 1988). Somite rotation and grafting experiments alsoulators that belong to the basic-helix-loop-helix (bHLH)
demonstrate that cells at the newly formed epithelialclass of DNA binding proteins (see reviews by Emerson,
somite and presomitic mesoderm are not committed to1990; Weintraub et al., 1991a). All members of this family
the dermomyotomal or sclerotomal lineage (Aoyamahave the remarkable property of converting a variety of
and Asamoto, 1988; Christ et al., 1992). Signals fromcells into myoblasts and myotubes (Weintraub et al.,
the surrounding tissue mediate a balance between the1989). The members of the MyoD family share consider-
formation of sclerotome and dermomyotome in distinctable amino acid sequence similarity, particularly in the
halves of the epithelial somite. The patterning of the70 amino acid bHLH domain. Additional homology
precise boundary between these two compartments inamong these proteins is in a cysteine/histidine (C/H) rich
immature somites and the maintenance of the sclero-region located immediately amino-terminal to the bHLH
tome and dermomyotome identities throughout em-domain. The basic region is required for specific DNA
bryogenesis are important steps for the proper forma-binding, and the HLH region is required for dimerization
tion of both tissues.(Davis et al., 1990). The function of the C/H region is not
Myogenic cell fate is controlled by the MyoD familyyet known. Myogenic factors heterodimerize with E12
of transcription factors, and the ectopic expression ofor E47, which are alternative splicing products of the
these factors can overcome many other preexisting cell
fates in vitro and in vivo (Weintraub et al., 1989; Miner
et al., 1992). Therefore, control of the precise expression³ Present address: Department of Genetics, Harvard Medical
and function of myogenic factors in both precursorsSchool, 200 Longwood Avenue, Boston, Massachusetts 02115.
§Deceased March 28, 1995. and progeny of the myotome is essential for normal
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Figure 1. The Predicted Amino Acid Se-
quence of I-mf Proteins
Three polypeptides, I-mfa, I-mfb, and I-mfc,
are encoded by the I-mf gene. Dashes indi-
cate that the amino acid at that position is
identical to I-mfa.
development. Similarly, the inhibition of expression/ Full-length I-mf cDNA clones were obtained by
screening mouse embryonic libraries using the cDNAfunction of myogenic factors in the sclerotome, which
is derived from the same precursors as the myotome, fragment isolated from the two-hybrid screen as probe
(see Experimental Procedures). Three classes of clones,is an essential component of early development.
To understand how the activity of myogenic factors designated I-mfa, I-mfb and I-mfc, were obtained and
subjected to further analysis. DNA sequencing and ge-is regulated during somitogenesis, we have used a yeast
two-hybrid screen to isolate embryonic proteins that nomic mapping revealed that these three different tran-
scripts are generated through differential poly(A) ade-specifically interact with, and are involved in regulating
the function of, MyoD. Below, we report the isolation nylation and alternative splicing (data not shown).
Deduced polypeptide sequences suggest that the threeand characterization of a novel myogenic repressor, I-mf
(Inhibitor of MyoD family). We show that I-mf is highly I-mf proteins share a common amino-terminal region,
but each has a different carboxyl terminus. The I-mfaexpressed in the sclerotome, where MyoD expression
is excluded. I-mf functions as a myogenic repressor that and I-mfb carboxyl termini are approximately equal in
size and comprise one third of each polypeptide. Theinhibits the transactivation activity of myogenic factors
by retaining these factors in the cytoplasm and interfer- third polypeptide, I-mfc, has a shorter unique carboxyl
terminus (Figure 1). GenBank Database searches of theing with their binding to target DNA sequences. Our
results suggest that I-mf may restrict the expression sequences of I-mf cDNAs and deduced I-mf proteins
revealed no homology with any known cDNA or protein.of myogenic factors and maintain the identity of the
sclerotome by preventing the function of myogenic fac- Interestingly, the sequences of all 15 clones isolated
from a random primed two-hybrid library were overlap-tors in the sclerotome.
ping, and all contained the unique carboxyl terminus of
I-mfa (data not shown). This result suggests that theResults
unique carboxyl terminus of I-mfa, which is character-
ized by its high content of cysteine residues, is involvedIsolation of I-mf cDNA, which Encodes
Three Novel Proteins in the interaction with MyoD.
The onset of myoD gene expression occurs at about
10.5 days postcoitum. Therefore, to isolate proteins that
potentially interact with and regulate MyoD function dur- I-mfa Specifically Interacts with MyoD
Family Members In Vitro and In Vivoing somitogenesis, we used a yeast two-hybrid screen
with a library containing the VP16 activation domain The yeast two-hybrid approach described above dem-
onstrated interaction between a truncated I-mf proteinfused to random-primed cDNA derived from mouse em-
bryos 9.5 and 10.5 days postcoitum (Vojtek et al., 1993; and a fragment of MyoD. A modified yeast one-hybrid
system employing a b-galactosidase (b-gal) reporterHollenberg et al., 1995). Amino acids 57 to 166 of MyoD,
encompassing the most conserved C/H rich and bHLH was used to determine if full length I-mf and MyoD inter-
act. Full-length MyoD with its own transactivation do-domains, were fused to the LexA DNA binding domain
and used as a ªbaitº (LexAMyoD57±166). From approxi- main was cotransformed with constructs containing the
LexA DNA binding domain fused to full length I-mfa, -b,mately 8 3 106 clones screened, 550 clones were se-
lected that showed specific interaction with the MyoD or -c (LexA±I-mfa, LexA±I-mfb, LexA±I-mfc, respec-
tively) into yeast strain L40. b-gal activities were deter-bait. From this collection, about 130 clones were identi-
fied as cDNA fragments encoding members of the E mined quantitatively in L40 yeast cells expressing differ-
ent combinations of these proteins. As shown in Tableprotein family and 100 clones encoding Id family mem-
bers (see Experimental Procedures), both of which are 1, L40 expressing LexA, LexA±I-mfa, LexA±I-mfb, or
LexA±I-mfc exhibited background levels of b-gal activi-known HLH partners of MyoD. From the remaining
clones, one gene called I-mf, which represented 15 inde- ties ranging from 0.1 to 0.9 (arbitrary units). However,
b-gal activity was 5-fold higher than the LexA±I-mfapendent VP16 fusions of 18 clones, was identified and
characterized further. control in the same yeast strain bearing LexA±I-mfa and
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Table 1. Interaction of the MyoD Family and Hybrid I-mf Proteins in Yeast Strain L40
b-Galactosidase activities in L40 yeast strains
LexA LexA±I-mfa LexA±I-mfb LexA±I-mfc LexA±Da
Vector 0.5 0.9 0.1 0.1 0.1
MyoD 0.6 4.3 1.1 0.4 12.5
Myf5 0.9 68.5 0.4 0.4 12.1
Myogenin 0.6 63.6 0.4 0.3 28.6
T3 1.6 2.3 0.9 0.1 12.9
E12 2.3 2.3 0.6 1.4 25.0
MyoDDN-VP16 0.9 96.4 ND ND 54.3
MyoDDC-VP16 0.6 5.6 ND ND 146.5
Exponential phase L40 yeast strains containing the indicated plasmids were assayed for b-galactosidase activity as described in Experimental
Procedures. (ND, not determined). All LexA fusion proteins in appropriate size were expressed at similar levels when assayed by Western
blot analysis (data not shown). The transactivation potencies of all bHLH activators tested are also comparable to one another as assayed
by the interaction with LexA±Da, a fusion protein containing LexA and a bHLH domain of Daughterless, the Drosophila homolog of mammalian
E proteins.
MyoD. In contrast, L40 expressing MyoD and LexA±I- I-mf Is Expressed in the Sclerotome,
a Subdomain of Somitesmfb or LexA±I-mfc exhibited only background levels of
b-gal activity, suggesting that MyoD can interact with To investigate the possible function of I-mf in embryonic
myogenesis, we first analyzed the expression patternI-mfa but not with I-mfb or I-mfc.
Since the MyoD sequence used in the original isolation of I-mfa during mouse embryogenesis. Parasagittal sec-
tions of mouse embryos at E11.5 were examined by inof I-mf is conserved among myogenic factors, we deter-
mined whether interaction between I-mf and other MyoD situ hybridization using a digoxygenin labeled antisense
riboprobe corresponding to the 39 region of the mousefamily members is detectable in this one-hybrid system.
Interestingly, in yeast expressing LexA±I-mfa and full- I-mfa sequence that encodes its unique carboxyl termi-
nus. As a comparison, sections adjacent to those exam-length Myf5 or myogenin, b-gal activity was about 70-
to 80-fold higher than in those expressing LexA±I-mfa ined for I-mfa expression were hybridized with a MyoD
alone. Consistent with the MyoD result, the interaction
with Myf5 or Myogenin was also specific to I-mfa (Table
1). In contrast, no stimulation of the b-gal reporter was
observed in L40 expressing LexA±I-mf and full-length
E12 or Lethal of Scute (AS-C T3), two other bHLH tran-
scriptional activators (Table 1). Our failure to detect sig-
nificant interaction between LexA±I-mfa and E12 or T3
suggests that I-mfa may interact specifically with the
myogenic family of bHLH proteins.
Physical association of I-mf and myogenic factors was
also demonstrated in an in vitro coprecipitation assay.
Figure 2A shows that 35S-labeled in vitro translated Myf5,
MyoD, and Myogenin are coprecipitated by a bacterially
expressed fusion protein containing the maltose binding
protein (MBP) and I-mfa (lane 2±4). In contrast, these
myogenic factors are not coprecipitated in the presence
of MBP±I-mfc (Figure 2A, lane 1; data not shown). No
significant association between E protein and I-mfa is
detectable in this assay (lane 5 of Figure 2A), further
suggesting that I-mfa may interact specifically with Figure 2. In Vitro and In Vivo Binding of I-mf Proteins to the MyoD
Family MembersMyoD family members.
To determine if the association between I-mfa and (A) In vitro±translated and [35S]methionine±labeled Myf5 (lanes 1 and
2), Myogenin (lane 3), MyoD (lane 4), and E12 (lane 5) were directlymyogenic regulatory factors occurs in mammalian cells,
analyzed by SDS-polyacrylamide gel electrophoresis (bottom panel)an immunoprecipitation assay was performed on ex-
or analyzed after precipitation with amylose resin following incuba-tracts from cells transiently transfected with expression
tion with purified MBP±I-mfc (lane 1) and MBP±I-mfa (lanes 2±5)
vectors encoding haemaglutinin (HA) epitope-tagged fusion proteins (upper panel).
I-mf (HA-I-mf) and wild-type MyoD. The upper panel of (B) Cell extracts were made from NIH3T3 cells transiently
transfected with expression vectors encoding Myf5 (lane 1) or MyoDFigure 2B shows that HA-I-mfa, but not HA-I-mfb or
(lanes 2±4) and HA epitope-tagged I-mfa (lanes 1 and 2), I-mfb (laneHA-I-mfc, is coprecipitated by MyoD antiserum in the
3), or I-mfc (lane 4). Western blot analyses were performed on thosepresence of MyoD protein. Similar results were also ob-
extracts with MyoD monoclonal antibody, 5.8A (bottom panel), ortained with Myf5 antiserum in extracts from cells ex-
anti-HA epitope antibody, 12CA5 (middle panel). The same extracts
pressing Myf5 and HA-I-mf (data not shown). These re- were also immunoprecipitated with MyoD antiserum and protein A
sults show that I-mfa and MyoD family members beads followed by detection of precipitates with anti-HA antibody,
12CA5, by Western blot analysis (upper panel).associate in vivo.
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Figure 3. Expression Pattern of the I-mf
Gene
In situ hybridization with digoxygenin-labeled
antisense riboprobes derived from I-mfa (A)
and MyoD (B) cDNA or with 35S-labeled anti-
sense riboprobes derived from I-mfa (C) and
Myf5 (D) cDNA were performed on adjacent
parasagittal sections (A and B) of E11.5
mouse embryos or adjacent transverse sec-
tions of the caudal region of E11.5 mouse
embryos. D, dermomyotome; DA, dorsal
aorta; DG, dorsal root ganglion; H, heart; L,
liver; N, neural tube; Sc, sclerotome; St,
stomach.
antisense riboprobe. As shown in Figure 3A, I-mfa tran- I-mfa Inhibits the MyoD Family-Dependent
Transcriptional Activationscripts are highly expressed in thesclerotome. However,
the expression of MyoD is concentrated in the myotome The transcripts of I-mfa, a MyoD-interactionprotein, and
the members of MyoD family accumulate in a mutually(Figure 3B). The transverse sections of caudal somites
of the same stage embyos show high level of I-mfa exclusive fashion in differentiating somites, suggesting
that I-mfa may play an important role in regulating theexpression in the sclerotome, the ventral subdomain of
the somites (Figure 3C), while Myf5 is detected exclu- expression/function of the MyoD family. To determine
if I-mfa influences the activity of myogenic factors, thesively in the myotome part of dermomyotome, the dorsal
subdomain of somites (Figure 3D). A similar expression ability of MyoD family members to transactivate an E
box±driven reporter construct was assayed in the pres-pattern of I-mfa was also observed in newly formed
somites of E8.5 mouse embryos (N. Kraut, unpublished ence or absence of I-mf. NIH3T3 cells were transiently
transfected with myogenic regulatory factors, I-mf, anddata). These results demonstrate a mutually exclusive
pattern of high level expression of I-mfa and the MyoD a chloramphenicol acetyltransferase (CAT) reporter
gene controlled by four copies of the E box sequencesfamily members in mouse somites.
In addition to its expression in somites, I-mfa is also (p4RCAT). I-mfa reduced the transactivation activity of
all three myogenic factors tested to 10%±23% of theexpressed in the notochord and at lower levels in the
neural tube (Figure 3C) as well as in limb buds, heart, control level (Table 2). In contrast, I-mfb and -c showed
no significant effect on the myogenic factor±dependentbranchial arches, head mesenchyme, and various other
parts of the mouse embryo (data not shown). Moreover, reporter activation. Moreover, I-mfa did not significantly
inhibit the transactivation activity of E12, constructedanalysis of RNA from various mouse tissues reveals that
I-mfa is most highly expressed in skeletal tissue, but is in the same expression vector as MyoD family members,
when assayed on the same reporter construct (Tableexpressed at lower levels in almost every other tissue
analyzed (data not shown). 2). This result demonstrates that I-mfa is not a general
I-mf Represses Myogenesis
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Table 2. The Effect of I-mf on the Transactivation Activities of the MyoD Family
Relative CAT Activity (%)
MyoD Myf5 Myogenin E12
Vector 100 100 100 100
I-mfa 23.1 6 13.6 9.8 6 11.5 10.3 6 7.5 76.3 6 10.9
I-mfb 111.2 6 19.0 87.6 6 10.8 72.1 6 11.8 89.9 6 15.5
I-mfc 118.6 6 28.6 98.0 6 3.4 66.4 6 12.0 106.5 6 22.3
The CAT activities were determined in NIH3T3 cells transiently transfected with the p4RCAT reporter together with combinations of expression
vectors as indicated. The CAT activity from each cotransfection of myogenic factors and I-mf was normalized to the value from each
cotransfection with empty vector to allow a direct comparison of the I-mf effect on each myogenic factor. The data represent the average of
relative values from 4 to 6 experiments for MyoD, Myf5, and Myogenin; 3 to 4 experiments for E12.
repressor of bHLH transcriptional activators, and is con- differentiated into elongated myotubes (Figures 4A±4C
and 4G±4L). However, consistent with the repressor ac-sistent with the possibility that the repression activity
of I-mfa may be specific to MyoD family members. We tivity of I-mfa, cells expressing both I-mfa and Myf5
demonstrated repression of muscle differentiation;have also observed that the I-mfa repression of myo-
genic regulatory factor activity occurs (i) in a dose- z80% of the Myf5-expressing cells showed no MyHC
expression and retained their fibroblast morphologydependent manner, (ii) in C3H10T1/2 cells cultured in
either growth medium or differentiation medium, and (iii) (Figures 4D±4F). Our results suggest that I-mfa can in-
hibit MyoD family-mediated muscle differentiation in tis-when assayed on a CAT reporter driven by 3.3 kb of
the muscle-specific MCK promoter (data not shown). sue culture cells.
Together, these results suggest that I-mfa represses the
transactivation activity of the MyoD family independent I-mfa Retains MyoD Family Members in the
Cytoplasm by Masking Their Nuclearof cell type, culture conditions and reporter constructs
used. Localization Signals
The previous results suggest that I-mfa suppresses
Myf5-mediated myogenesis by inhibiting the transacti-I-mfa Inhibits Myf5-Mediated Muscle Differentiation
Having shown that I-mfa modulates the transactivation vation activity of these factors. A potential mechanism
of this inhibition is suggested by the alteration in theactivities of myogenic factors, we next asked if I-mf can
inhibit MyoD family-dependent myogenesis. I-mfa and subcellular localization of Myf5 when coexpressed with
I-mfa: in the presence of I-mfa, Myf5 remains predomi-Myf5 were coexpressed transiently in NIH3T3 fibro-
blasts, and muscle differentiation was assayed by the nantly in the cytoplasm (see Figure 4D). To determine if
the cytoplasm-expressed Myf5 iscolocalized with I-mfa,appearance of the specific muscle marker myosin heavy
chain (MyHC), as well as by cellular morphology. When NIH3T3 cells were transfected with expression con-
structs encoding Myf5 and HA epitope-tagged I-mf. Indi-cotransfected with Myf5 and different control vectors,
z80% of the Myf5 positive cells expressed MyHC and rect immunofluorescence staining was performed using
Figure 4. The Effect of I-mf Proteins on Myf5-
Mediated Myogenesis
A Myf5 expression vector was transiently
transfected into NIH3T3 cells together with
the control expression vector (A±C), the same
expression vector encoding I-mfa (D±F),
I-mfb (G±I), or I-mfc (J±L). Twenty-four hours
after transfection, cells were grown in differ-
entiation medium for an additional 40 hr be-
fore staining. Double immunofluorescent
staining was performed with a Myf5 antise-
rum (A, D, G, and J) and theanti-myosin heavy
chain (MyHC) monoclonal antibody, MF20 (B,
E, H, and K), followed by incubation with Fluo-
rescein-conjugated anti-rabbit Ig antibody
and Rhodamine-conjugated anti-mouse Ig
antibody, respectively. Superimposed im-
ages of Myf5 and MyHC staining are shown
in (C), (F), (I), and (L).
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Figure 5. Subcellular Localization of Myf5
and I-mf Proteins
Myf5 (A±I) or NLSMyf5 (J±L) expression vec-
tors were transiently transfected into NIH3T3
cells together with expression vectors encod-
ing HA epitope-tagged I-mfa (A±C, J±L), I-mfb
(D±F), or I-mfc (G±I). Forty hours after trans-
fection, cells were double immunostained
with Fluorescein-conjugated anti-rabbit Ig
antibody following Myf5 antiserum staining
(A, D, G, and J), and Rhodamine-conjugated
anti-mouse Ig antibody following staining
with anti-HA epitope monoclonal antibody,
12CA5 (B, E, H, and K). Images of Myf5 and
HA-I-mf staining were superimposed in (C),
(F), (I), and (L). Based on the intensity of stain-
ing, Myf5 was expressed at comparable lev-
els in cells cotransfected either with control
vector, I-mfa, I-mfb, or I-mfc.
Myf5 and anti-HA antibodies. Figure 5 shows that I-mfa NLSMyf5 and I-mfa. Thus, the rescue of nuclear localiza-
tion of Myf5 by the SV40 NLS suggests that I-mfa se-protein is distributed primarily throughout the cyto-
questers myogenic regulatory factors in the cytoplasmplasm, although weak staining is detectable in the nu-
through direct protein interaction which masks the NLScleus. This subcellular localization does not change in
of these factors.the presence of Myf5 (Figures 5B, 5E, and 5H). In the
absence (data not shown) or in the presence of I-mfb
or I-mfc (Figures 5D and 5G), Myf5 is localized exclu- I-mfa Interferes with the DNA Binding Activity
sively in the nucleus. In contrast, when coexpressed of the MyoD Family Members
with I-mfa, Myf5 protein colocalizes with I-mfa in the As shown above, the nuclear localization of Myf5 can
cytoplasm (Figures 5A±5C). Similar analyses with other be rescued by addition of the SV40 NLS. To determine
myogenic factors revealed that I-mfa retains Myogenin if the rescueof nuclear localization issufficient to restore
equally well in the cytoplasm, but it retains MyoD to Myf5-mediated myogenesis in the presence of I-mfa,
a lesser degree (data not shown). The I-mfa-mediated we examined the expression of MyHC in NIH3T3 cells
cytoplasmic retention may be specific to myogenic fac- transiently transfected with NLSMyf5 and HA-tagged
tors, since the nuclear localization of E protein remained I-mf expression vectors. NLSMyf5 alone induced MyHC
unchanged when coexpressed with I-mfa (data not expression in transfected NIH3T3cells toa similar extent
shown). These results suggest a correlation among the as wild-type Myf5 (Figures 6A±6C). In contrast, when
binding, repression, and cytoplasmic retention of the coexpressed with I-mfa, most NLSMyf5-expressing
MyoD family by I-mfa. cells did not express detectable MyHC protein (Figures
MyoD has two nuclear localization signals (NLS), one 6D±6F), similar to what has been observed with Myf5
in the basic region and one in the helix 1 domain (Van- in the presence of I-mfa. This result suggests that the
dromme et al., 1995). The location of these NLS overlaps nuclear NLSMyf5 is functionally impaired in the pres-
with the I-mf interaction region, raising the possibility ence of I-mfa. In a parallel experiment, we found that
that I-mfa may simply mask the NLS of the MyoD family the transactivation activity of NLSMyf5 was also re-
members, resulting in their cytoplasmic retention. If this pressed by I-mfa (data not shown). These results imply
masking hypothesis were correct, adding a presumably that the sequestration of myogenic regulatory factors in
unmasked NLS outside of the C/H rich and bHLH regions the cytoplasm is not the sole mechanism by which I-mfa
of myogenic regulatory factors should restore their nu- inhibits the activities of the MyoD family members.
clear localization. To test this hypothesis, one SV40 T The I-mfa interacting region of myogenic regulatory
antigen NLS was added to the amino terminus of Myf5 factors also overlaps with the DNAbinding and dimeriza-
(NLSMyf5). When coexpressed with I-mfa in NIH3T3 tion domains of these proteins. Thus, gel shift assays
cells, NLSMyf5 localized exclusively in the nucleus (Fig- with an E box containing probe (B1/B2) were performed
ures 5J±5L). A similar ªnuclear rescueº was observed todetermine whether I-mfa interferes with the DNA bind-
for NLSMyogenin and NLSMyoD (data not shown). Since ing and/or dimerization of myogenic factors. As shown
I-mfa associates equally well with NLSMyf5 and Myf5 in Figure 7, homodimers of in vitro translated Myogenin
in both coprecipitation (data not shown) and gel shift bound the B1/B2 probe and formed a low mobility com-
assays (see Figure 7B), it is unlikely that the nuclear plex (Figure 7A, lane 2). A fusion protein (MBP±I-mfaDN)
containing the unique I-mfa domain from amino acid 163rescue is due to a failure in association between
I-mf Represses Myogenesis
737
Figure 6. The Effect of I-mf proteins on NLSMyf5 Mediated-Muscle Differentiation
A NLSMyf5 expression vector was cotransfected into NIH3T3 cells with expression vectors encoding HA epitope (A±C), HA epitope-tagged
I-mfa (D±F), or HA epitope-tagged I-mfc (G±I). Twenty-four hours posttransfection, cells were grown in differentiation medium for an additional
40 hr before they were stained with antibodies. Double immunostaining was performed with Myf5 antiserum (A, D, and G) and anti-MyHC
monoclonal antibody, MF20, (B, E, and H) followed by staining with Fluorescein-conjugated anti-rabbit Ig antibody and Rhodamine-conjugated
anti-mouse Ig antibody, respectively. Superimposed images of Myf5 and MyHC staining are shown in (C), (F), and (I).
to 246, which is sufficient for interaction with myogenic activity of E47 was not affected by I-mfaDN even when
present in a 192-fold molar excess (Figure 7A, lane 11±factors (Chen, 1996), competed with this complex for-
mation in a dose-dependent manner (Figure 7A, lanes 14), suggesting that I-mfa may interfere specifically with
DNA binding of myogenic factors. Figure 7B shows that3±8). Interference of 50% was observed when MBP±I-
mfaDN was present in 3- to 5-fold molar excess. As a MBP±I-mfaDN also interferes with the DNA binding ac-
tivities of E12/Myogenin, E12/MyoD, E12/Myf5,and E12/control, the MBP fusion proteins containing either the
unique carboxyl domain of I-mfb (amino acid 164 to 251) NLSMyf5 heterodimers. However, up to 60- to 120-fold
molar excess of MBP±ImfaDN is required for 50% inhibi-or full-length I-mfc showed no effect on Myogenin DNA
binding, even when present in 48-fold molar excess (Fig- tion of the DNA binding activity of these heterodimers.
These results suggest that I-mfa can inhibit the functionure 7A, lane 9 and 10). In addition, the DNA binding
Figure 7. The Effect of I-mf proteins on DNA-
Binding Activities of the MyoD Family
(A) In vitro translated Myogenin (lanes 2±10)
was incubated with either no protein (lane 2),
increasing molar ratios (by a factor of 2) of
purified MBP±I-mfaDN proteins (from a 1.5-
fold to a 48-fold molar excess, from lane 3 to
lane 8), or a 48-fold molar excess of MBP±I-
mfbDN and MBP±I-mfc (lanes 9 and 10, re-
spectively). In vitro translated E47N (Sun and
Baltimore, 1991) was also incubated with ei-
ther no protein or with a 192-fold molar ex-
cess of MBP±I-mfaDN, MBP±I-mfbDN, or
MBP±I-mfc (lane 11 to 14). An electrophoretic
mobility shift assay was then performed after
adding the labeled B1/B2 probe.
(B) In vitro translated Myogenin (lane 1±4),
MyoD (lane 5±8), Myf5 (lane 9±12), and
NLSMyf5 (lane 13±16) were incubated with in
vitro±translated E12 together with no MBP
fusion protein (lanes 1, 5, 9, and 13) or an
increasing molar excess (by a factor of 2) of
bacterially purified MBP±I-mfaDN from a 48-
to 192-fold molar excess relative to Myogenin (lanes 2±4) or from a 160- to 640-fold molar excess relative to MyoD, Myf5, and NLSMyf5 (lane
6±8, 10±12, and 14±16, respectively). Gel electrophoresis was conducted after addition of the labeled B1/B2 probe. Asterisk indicates the
heterodimer complex.
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of myogenic factors by interfering with their binding to with MyoD than with other myogenic regulatory factors
in mouse embryos. I-mfaalso had slightly weaker effectsDNA target sites. This interference could be mediated
through an inhibition of dimerization bybinding tomono- on MyoD than on the other myogenic factors tested in
both transactivation repression and cytoplasmic reten-mers of the MyoD family members (see Discussion) or
through an effect on DNA binding per se. tion assays.
Discussion The Function of I-mfa in Myogenesis
Early in development, I-mfa, a repressor of myogenesis,
We have isolated a novel sclerotome-expressed myo- is highly expressed in the sclerotomal domain of so-
genic repressor, I-mfa, which interacts with members mites. In contrast, myogenic factors are detected in the
of the MyoD family. I-mfa represses both transcriptional dermomyotomal domain of somites. This mutually ex-
activation and myogenesis mediated by the MyoD fam- clusive pattern of high level expression in developing
ily. These repressor activities of I-mfa appear to be due somites suggests a model for the function of I-mfa dur-
to its ability to mask the NLS of myogenic regulatory ing myogenesis: in response to signals from the noto-
factors, thereby causing the cytoplasmic retention of the chord or neural tube, the expression of I-mfa is elevated
MyoD family, and/or its interference with MyoD family in the sclerotomal precursors, thereby inhibiting the
members binding to DNA. transactivation activities of Myf5 and MyoD and their
auto-regulation and cross-regulation loops in the sclero-
tome, but not in the dermomyotome.Three Transcripts Are Encoded
Sclerotomal and dermomyotomal cells are derivedby the I-mf Gene
from the same precursors in immature somites. InAt least three polypeptides are encoded by the I-mf
mouse embryos, low levels of Myf5 transcripts are de-gene during mouse embryogenesis. Each contains a
tectable in the immature somites (Ott et al. 1991), ascommon amino-terminal region and a diverse carboxy-
well as in unsegmented presomitic mesoderm (Kopanterminal region. I-mfa interacts with MyoD family mem-
et al., 1994). Myf5 protein is detected inoccasional scler-bers and functions as a myogenic repressor. In contrast,
otomal cells (Smith et al., 1994), further supporting theI-mfb and I-mfc do not interact with the MyoD family in
notion that myogenic repressors are required in theany of the systems used in our analyses. The sequence
sclerotome to restrain the high level expression of myo-diversity among these three I-mf transcripts clearly sug-
genic factors. The finding of rib defects in Myf5, Myo-gests that the unique carboxy-terminal region of I-mfa
genin, or MRF4 homozygous mutant mice (Olson et al.,is the domain required for the interaction with MyoD
1996, and references therein) also suggests a possiblefamily members and myogenic repression.
interplay between dermomyotome and sclerotome de-While our results suggest that I-mfa may function as
rivatives. The presence of I-mfa in the sclerotome pro-a myogenic repressor, the functions of I-mfb and I-mfc
vides a potential regulatory mechanism for the controlare unknown. I-mfb contains a unique 90 amino acid
of cell fate determination in both dermomyotome andcarboxyl terminus, which is about the same size as the
sclerotome: in the early stage of somite differentiation,unique carboxyl terminus of I-mfa. Since the carboxyl
I-mf may specify the dorsal-ventral pattern by negativelyterminus of I-mfa is the region responsible for interacting
regulating myogenic factors in the ventral part of so-with the MyoD family, we speculate that the correspond-
mites. In the later stage, I-mfa may also maintain theing region of I-mfb might interact with as yet unidentified
identity of sclerotomal cells by preventing the sclero-targets. In contrast to I-mfa and I-mfb, I-mfc contains
tome cells from switching their cell fate into myoblasts.a relatively short 28-residue unique carboxyl terminus,
However, we can not rule out the possibility that I-mfawhich may also provide interaction specificity with its
maybe directly involved in the formation or developmentown targets. Clearly, the idea of specific targets for each
of the sclerotome, possibly by affecting the activity ofpolypeptide encoded by the I-mf gene requires further
scleraxis, a sclerotomal expressed bHLH (Cserjesi et al.,investigation.
1995) or other yet to be identified bHLH proteins in the
sclerotome.I-mfa Interacts with Members of the MyoD Family
Yeast one-hybrid and both in vitro and in vivo coprecipi-
tation assays demonstrate that I-mfa associates with The Mechanism of I-mfa-Mediated
Myogenic Repressionmembers of the MyoD family. The well-defined HLH di-
merization domain of MyoD is required for interaction I-mfa is one of the few known direct inhibitors of myo-
genic bHLH factor function. Id inhibits myogenesis di-between bHLH proteins; however, it is not sufficient for
interacting with I-mfa. The Helix 2 domain of MyoD is rectly by forming nonfunctional heterodimers with myo-
genic factors and indirectly by titrating out E12 or E47also dispensable for this interaction (Chen, 1996), sug-
gesting that the interaction property of MyoD/I-mfa is (Jen et al., 1992). Mtwist inhibits myogenesis by pre-
venting trans-activation of muscle target genes by thedifferent from that of bHLH dimerization.
In the yeast assay system, I-mfa interacts with MyoD MEF2 family of myogenic regulatory factors and by titrat-
ing Eproteins away from myogenic bHLH factors (Spicermore weakly than with Myf5 or Myogenin (Table 1); anal-
ysis of various MyoD-deletion constructs suggests this et al., 1996).
Our results show that I-mfa can only weakly interfereweak interaction between MyoD and I-mfa is likely due
to interference from the amino terminus of MyoD (Table with DNA binding of MyoD/E12 (Figure 7B), suggesting
that I-mfa might recognize monomers of MyoD family1). However, it is unclear if I-mfa associates more weakly
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serve as a color indicator when screening for the yeast trans-members. This possibility is supported by the findings
formants that lose bait constructs. The two-hybrid screen was per-that the trans-activation activity of MyoD/E47 forced-
formed as described previously (Vojtek et al., 1993; Hollenberg etdimers (Neuhold and Wold, 1993) is resistent to I-mfa;
al., 1995) with some modifications. The His1LacZ1 clones were
the nuclear localization of Myf5 can also be rescued by plated out in cloning density on synthetic plates lacking leucine and
high level expression of E12 in the presence of I-mfa containing 0.01 g/l of adenine. A single colony carrying only library
constructs, indicated by its uniform red color, was selected from(C.-M. A. Chen, unpublished data). In the early stage
each clone for further analysis. Those yeast clones were mated withof somite development, I-mfa may interact with Myf5
AMR70 strain carrying LexA fusions containing lamin, the bHLH ofmonomers, while E12 is complexed with Id and/or
Da or Th1 (Hollenberg et al., 1995) to identify false positive clones,Mtwist. I-mfa, Id, and Mtwist may work in concert: Id
clones encoding Id or E protein family members, respectively. The
and Mtwist preferentially interact with and sequester clones encoding members of the Id and E protein families were
E12, while I-mfa interacts with myogenic bHLH proteins further confirmed by sequence analysis.
Full-length I-mfa was cloned from an E10 mouse embryonic cDNAand inhibits their nuclear localization and DNA binding
library (Novagen) using one of the I-mf cDNA inserts isolated fromactivities. Interestingly, the expression pattern of I-mfa
the two-hybrid screen as a probe. I-mfb and -c were cloned fromin the developing mouse embryo overlaps considerably
an E16 mouse embryonic cDNA library (Novagen) using full-lengthwith the expression of Mtwist and Id (Wolf et al., 1991;
I-mfa as probe. I-mfa, -b, and -c were subcloned into pBluescript
Wang et al., 1992; N. Kraut et al., unpublished data): all and sequenced.
three genes are expressed in the sclerotome but not in
the myotome. Futhermore, their expression outside of Plasmid Constructs
The deduced protein coding regions of I-mfa, -b, and -c were PCRsomites also shows considerable overlap, suggestive
amplified and subcloned into the EcoRI±XhoI sitesof the mammalianof possible regulatory interactions.
expression vector pCS2 (Rupp et al., 1994; Turner and Weintraub,Our results suggest that I-mfa represses the function
1994) and pCS2HA to generate pCS-I-mfa, -b, -c and pCSHA-I-
of MyoD family members via retaining them in the cyto- mfa, -b, -c, respectively. pCS2HA is a pCS2 derivative containing
plasm by masking their NLS. Accumulating evidence duplicated haemaglutinin epitopes generated by inserting a DNA
suggests that alternation of subcellular localization is fragment into the ClaI site of pCS2. The blunted EcoRI±HindIII frag-
ments of I-mfa and I-mfb, blunted PpuMI±HindIII fragment of I-mfcan important mechanism in regulating the functions of
were also constructed in-frame into pBTM116 to generate pLexA±I-proteins (see reviews by Whiteside and Goodbourn
mfa, -b and -c. The PCR-amplified fragments containing the full1993; Vandromme et al., 1996, and references therein).
length coding region or amino acid 163 to 246 of I-mfa were cloned
For example, similar to the regulation of myogenic fac- in-frame into pMAL-c2 (New England Biolab) to construct pMBP±I-
tors by I-mfa, the activity of the NF-kB family is inacti- mfa and pMBP±I-mfaDN, respectively. A PpuMI±HindIII fragment of
vated by interaction with I-kB family members that mask I-mfc cDNA and EcoO109I fragment of I-mfb cDNA, which contains
full-length I-mfc and amino acids 164 to 251 of I-mfb, were alsothe NF-kB NLS, thereby retaining them in the cytoplasm
cloned in-frame into pMAL-c2 to generate pMBP±I-mfc and(reviewed by Liou and Baltimore, 1993; Beg and Bal-
pMBP±I-mfbDN constructs, respectively. pEMBLMyoD, pEMBL-dwin, 1993; Verma et al., 1995). Similar to I-mfa, I-kB
Myf5, and pEMBLMyogenin for the yeast one-hybrid assay were
proteins also act as inhibitors of NF-kB DNA binding by constructed by cloning PCR amplified protein coding regions of
disrupting preformed NF-kB-DNA complexes (Zabel and mouse MyoD, Myf5, and Myogenin cDNA, respectively, into yeast
Baeuerle, 1990). However, the extent of molecular simi- expression vector pEMBLye30/2 (Banroques et al., 1986). The same
PCR products of Myf5 and Myogenin were also subcloned intolarity that may exist between these two systems requires
mammalian expression vector pEMScribe (Davis et al., 1987) orfurther investigation.
pCS2NLS (Rupp et al., 1994) to make pEMSVMyf5 and pEMSVMyo-A ªcytoplasmic anchorº of MyoD, which would func-
genin or pCSNLSMyf5 and pCSNLSMyogenin, respectively.
tion similarly to I-mfa, has been proposed to be an im-
portant regulator of cell fate in Xenopus embryos (Rupp Yeast Quantitative b-Galactosidase Activity Assays
et al., 1994). The transcriptional activation of Xenopus S. cerevisiae strain L40 was transformed by the standard lithium
MyoD (XMyoD) occurs at a low level throughout the acetate method and transformant colonies were used for b-galac-
tosidase assays as described (Trawick et al., 1989). The b-galac-embryo at and shortly after the midblastula transition
tosidase units were calculated using the formula: (OD420 3 1000)/(MBT). However, XMyoD accumulates to a high level
(OD600 3 reaction time in minutes).only in the presumptive mesoderm (Harvey, 1991; Rupp
and Weintraub 1991). The XMyoD protein, which is also
In Vitro and In Vivo Coprecipitation Assays
expressed ubiquitously around MBT, appears to be lo- MBP±I-mf fusion proteins were purified using a bacterial expression
calized in nuclei in the presumptive mesoderm. In the system as described (Vojtek et al., 1993). bHLH proteins were syn-
thesized in vitro using a TNT-coupled reticulocyte system and la-ectoderm, XMyoD is retained in the cytoplasm through
beled with [35S]methionine, according to the instructions of the man-a putative cytoplasmic anchoring mechanism (Rupp et
ufacturer (Promega). For the in vitro association assay, appropriateal. 1994). Thus, the inhibition of function of myogenic
aliquots of [35S]methionine labeled bHLH proteins were mixed withfactors by I-mfa-like molecules may be an important
1 mg of purified MBP±I-mf fusion proteins in 30 ml of phosphate-
paradigm of early vertebrate development. buffered saline (PBS) and incubated for 1 hr at room temperature.
Twenty-five microliters of a 50% suspension of amylose resin (New
England Biolabs) and 1 ml of washing buffer containing 20 mM
Tris±HCl (pH 7.4), 150 mM NaCl, 5 mM MgCl2, 0.1% NP-40 (TNMExperimental Procedures
buffer) were then added, followed by 30 min incubation at room
temperature. The bound protein complex and resin were washedYeast Two-Hybrid Screening and Mouse Library Screening
pLexAMyoD57±166, MyoD bait, was constructed by PCR amplifica- five times with TNM buffer. Prior to analysis on SDS-polyacrylamide
gel and detection by autoradiography, the bound proteins weretion of the MyoD insert from pEMSVMyoDDNDC (Weintraub et al.,
1991b) and cloned in-frame into the pBTM116 vector. The Ade2 eluted from the resin with 20 mM maltose in PBS.
For in vivo association assays, NIH3T3 cells were transfectedgene, isolated as a BamHI fragment from pL909 plasmid (a gift from
R. Keil), was cloned into the PvuII site of the MyoD bait plasmid to with expression vectors encoding MyoD and HA tagged I-mf. Cell
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extracts were made 40 hr posttransfection by sonicating in TNM RNA maturase gene transfered to the yeast nucleus can control
mitochondrial mRNA splicing. Cell 46, 837±844.buffer containing 50 mg/ml of Pefabloc (Boehringer Mannheim), 2
mg/ml of Leupeptin, 1 mg/ml of Aprotinin. Five microliters of MyoD Beg, A.A., and Baldwin, A.S., Jr. (1993). The I-kB proteins: multifunc-
antiserum and 25 ml of 50% suspension of protein A agarose were tional regulators of Rel/NF-kB tanscription factors. Genes Dev. 7,
added to the appropriate aliquot of cell extract in 1 ml TNM buffer 2064±2070.
containing the same proteinase inhibitors. The protein A agarose
Brand-Saberi, B., Ebensperger, C., Wilting, J., Balling, R., and Christ,complex was washed 5 times with TNM buffer after 1.5 hr incubation
B. (1993). The ventralizing effect of the notochord on somite differen-at 48C. Protein complexes were then eluted with SDS protein sample
tiation in chick embryos. Anat. Embryol. 188, 239±245.buffer prior to analysis by Western blotting using peroxidase-conju-
Buckingham, M. (1994). Muscle differentiation. Which myogenic fac-gated anti-HA (12CA5) antibody (Boehringer Mannheim) and the
tors make muscle? Curr. Biol. 4, 61±63.ECL detection system.
Buffinger, N., and Stockdale, F.E. (1994). Myogenic specification in
RNA In Situ Hybridization somites: induction by axial structures. Development 120, 1443±
In situ hybridization was performed as described (Hurlin et al., 1995; 1452.
Lee et al., 1995). Mouse embryos at stage E11.5 from inbred strain
Chen, C.-M.A. (1996). Identification and characterization of I-mf, a
BL/6 were collected for RNA in situ hybridization. Antisense RNA
novel myogenic repressor that interacts with MyoD family members.
corresponding to full length cDNA of murine MyoD (1.8 kb), murine
Ph.D. thesis. University of Washington. Seattle, Washington.
Myf5 (from the 424 bp DraI restriction fragment of the 59untranslated
Christ, B., Brand-Saberi, B., Grim, M., and Wilting, J. (1992). Localregion), and I-mf corresponding to I-mfa amino acid 71 to 34 bp
signaling in dermomyotomal cell type specification. Anat. Embryol.downstream of its stop codon (560 bp) were used as probes for
186, 505±510.hybridization.
Cserjesi, P., Brown, D., Ligon, K.L., Lyons, G.E., Copeland, N.G.,
Cell Transfection and CAT Assays Gilbert, D.J., Jenkins, N.A., and Olson, E.N. (1995). Scleraxis: a basic
NIH3T3 cells were grown in Dulbecco's modified Eagle's medium helix-loop-helix protein that prefigures skeletal formation during
(DMEM) supplied with 10% fetal calf serum. Five micrograms of mouse embryogenesis. Development 121, 1099±1110.
myogenic factor expression plasmids, 5 mg of I-mf expression vec- Davis, R.L., Weintraub, H., and Lassar, A.B. (1987). Expression of a
tors, and 5 mg of p4RCAT reporter constructs (Weintraub et al., single transfected cDNA converts fibroblasts to myoblasts. Cell 51,
1991b) were transfected on 10 cm dishes by the calcium phosphate 987±1000.
precipitation method (Davis et al., 1990). The next day, cells were
Davis, R.L., Cheng, P.-F., Lasser, A.B., and Weintraub, H. (1990).rinsed with phosphate-buffered saline and incubated for 10 hr in
The MyoD DNA binding domain contains a recognition code forDMEM plus 10% calf serum, then switched into differentiation me-
muscle-specific gene activation. Cell 60, 733±746.dium, DMEM plus2% horse serum, for an additional 40 hr. Cells were
Emerson, C.P. (1990). Myogenesis and developmental controlharvested for CAT assays as described (Weintraub et al., 1991b) or
genes. Curr. Biol. 2, 1065±1075.fixed for indirect immunofluorescence staining.
Fan, C.-M., and Tessier-Lavigne,M. (1994). Patterning of mammalian
Indirect Immunofluorescence Staining somites by surface ectoderm and notochord: evidence for sclero-
Cells were fixed in PBS with 4% of paraformaldehyde for 3 min and tome induction by a hedgehog homolog. Cell 79, 1175±1186.
permeabilized in PBS with 0.25% Triton X-100 for 3 min. Cells were
Goulding, M., Lumsden, A., and Paquette, A.J. (1994). Regulationthen stained with anti-myosin heavy chain monoclonal antibody,
of Pax-3 expression in the dermomyotome and its role in muscleMF20, anti-Myf5 polyclonal antibody (Santa Cruz), anti-HA mono-
development. Development 120, 957±971.clonal antibody, 12CA5 (Boehringer Mannheim).Fluorescein (DTAF)-
Harvey, R.P. (1991). Widespread expression of MyoD genes in Xeno-conjugated donkey anti-rabbit Ig and Rhodamine (TRITC)-conju-
pus embryos is amplified in presumptive muscle as a delayed re-gated goat anti-mouse Ig (Jackson ImmunoResearch Laboratories)
sponse to mesoderm induction. Proc. Natl. Acad. Sci. USA 88, 9198±were subsequently used for indirect fluorescence staining.
9202.
DNA Binding Assays Hollenberg, S.M., Sternglanz, R., Cheng, P.F., and Weintraub, H.
Gel shifting assays were performed as described (Davis et al., 1990). (1995). Identification of a new family of tissue-specific basic helix-
In brief, in vitro translated myogenic factors were mixed with purified loop-helix proteins with a two-hybrid system. Mol. Cell. Biol. 15,
bacterially expressed MBP±Imf proteins and incubated for 10 min 3813±3822.
at 378C. Prior to their analysis by gel electrophoresis in 0.53 TBE, Hurlin, P.J., QueÂva, C., Koskinen, P.J., SteingrõÂmssan, E., Ayer, D.E.,
the mixtures were incubated for 10 min with cocktails containing Copeland, N.G., Jenkins, N.A., and Eisenman, R.N. (1995). Mad3
buffer, dIdC, and 32P-labeled B1/B2 probe (Davis et al. 1990), con- and Mad4: novel Max-interacting transcriptional repressors that
taining E box sequences from the MCK promoter. suppress c-myc dependent transformation and are expressed dur-
ing neural and epidermal differentiation. EMBO J. 14, 5646±5659.
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